Market Research Blog

According to the latest research by FMI, portable MRI are set to witness a high growth of CAGR 6.8% during the year 2021-2031.

Portable MRI is an emerging tool during the COVID-19 pandemic. The introduction of low cost solutions in terms of portable MRI scanners is expected to enable new point-of-care and monitoring applications. With existing MRI scanners in centralized settings, accessibility and reduction of cost is primal.

Upcoming advancements in computational technology, hardware as well as expanding scanning-based technology industry in developing economies is set to effectively lead towards boosting sales of portable MRI.

Factors associated with the compatible applications of portable MRI in hospital environment and the reduced risk associated with lower magnetic strength of portable MRI are set to advance imaging services with expense mitigation, globally.

Portable MRI sales are expected to greater expansion over the forecast period owing to the strength of the factors mentioned above.

Request a sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-14215

What is Driving Demand for Portable MRI?

The demand for portable MRI is driven by the premise of expansive reach of MRI through cost reduction. The applications of portable MRI provide support in terms of cost, sitting and operational burdens which is directly applicable to benefitting the overall healthcare development by increasing the access to MRI examinations for a larger number of patients. Additionally, portable MRI yields a higher rate of use with varied applications.

Not to mention, in cases of acute neurological settings, the application of portable MRI will positively impact patient health with non-invasive and time-sensitive neuroimaging. The benefits of this approach can potentially be employed in the assessment of neurological injury in various medical setups, including environments with limited resources.

Which Factors are likely to Augment Growth of Portable MRI?

Technological advancements in terms of MRI scanners, especially specialty scanners has introduced a unique method of imaging. The costs associated with such scanners exhibited sub-optimal commercialization as compared to the prevailing models. The augmentative factor which provides leverage to portable MRI sales is the ease of access and potential for commercialization because of the advent of the COVID-19 pandemic.

Discover more about report analysis with figures and data tables, along with the table of contents. Request TOC- https://www.futuremarketinsights.com/toc/rep-gb-14215

U.S. and Canada Portable MRI Outlook

Introduction of COVID-19 pandemic over the globe impacted the magnetic resonance departments across the United States in terms of reduced procedure volume. The region of North America is expected to exhibit growth in terms of portable MRI sales over the forecast period. The growth is catalyzed by the increasing patient pool in the region as well globally, and rising awareness towards early diagnosis of diseases.

To quote health information provided by the Govt. of Canada on their website “44% of adults 20+ have at least 1 of 10 common chronic conditions”. Portable MRI demand in Canada is expected to increase over the forecast period owing to the rising prevalence of chronic diseases and growing geriatric population.

Europe Demand Outlook for Portable MRI

The region of Europe is projected to occupy a large share after North America in the adoption of portable MRI due to the rising prevalence of chronic diseases in the region, as well as increasing technological advancements, resulting in high demand for medical imaging devices.

The growth is also associated with the growing popularity of teleconsultation and teleradiology in the region, especially in countries like Germany. Demand of portable MRI in the region is lucrative and based upon the premise to fight cancer by employing cost-efficient and accessible diagnostic imaging solutions.

Who are the Key Manufacturers and Suppliers of Portable MRI?

Key companies operating in manufacturing and supply of Portable MRI are

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Canon Medical Systems
• Hyperfine
• Voxelgrids
• PrizMed Imaging.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/14215

Portable MRI market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

According to the latest research by Future Market Insights, interlaminar device market is set to witness a growth 5.4% during the year 2021-2031. Interlaminar device normally relates to the disease defined by the compression of nerve roots and shrinking of the spinal canal due to many pathologic causes, further leads to symptoms such as pain with a tingling feeling, numbness, and weakness. Spinal stenosis can include the cervical, lumbar, or thoracic (rarely) spine.

What is Driving Demand for Interlaminar Device?

The growth for interlaminar device is driven by various factors including advancements in spine surgery technologies, increasing incidence of spinal disorders, the launch of advanced bone grafting products, and the increasing adoption of minimally invasive spine surgeries.

Furthermore, key players across the globe focus on advancements in terms of technology to improve the interlaminar device efficacy and expanding their application in the market and assist with inventive growth opportunities. Furthermore, introducing unique product in the market allows businesses to acquire a competitive edge and increase product adoption.

Request a sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-14214

Which factors are likely to Augment Growth of Interlaminar Device Market?

The growth of interlaminar device is likely to be boosted by technological factors which benefits include a shorter hospital stay and recovery time, faster and longer-lasting relief from discomfort, better treatment adaptability, and adjacent layers are naturally moving.

For instance, in May 2018 Paradigm Spine disposable instrument kit coflex® Interlaminar stabilization gets FDA pre-market approval. Coflex® interlaminar stabilization is an exclusive posterior lumbar motion preservation solution which offers long-term outcomes for patients with moderate to severe spinal stenosis.

The region of North America accounts for highest market share in the current scenario for interlaminar device. The increasing adoption and penetration of interlaminar device into US and Canada market is mainly due to  a rise in the number patients with spinal cord injury, better healthcare facilities, and organizations like the North American Spine Foundation all working to raise awareness and educate healthcare providers and public about different medical condition.

As per data published by National Spinal Cord Injury Statistical Center, in 2017, approximately 285,000 people in the U.S. are estimated to be suffering from spinal cord injuries.

Discover more about report analysis with figures and data tables, along with the table of contents. Request TOC- https://www.futuremarketinsights.com/toc/rep-gb-14214

Europe Demand Outlook for Interlaminar Device

The European region is set to witness a dominant demand for interlaminar device due to the improving healthcare infrastructure, rising awareness, improving reimbursement scenario, and the growing insurance coverage are the major key factor to boost the growth in European region.

Some other factors are rising treatment rates for degenerative spine diseases, rising geriatric population, medical technological advances, and a growth in the demand for minimally invasive treatments are all contributing factors to this trend in Europe.

Who are the Key Manufacturers and Suppliers of Interlaminar Device?

The key companies operating in manufacturing and supply of interlaminar device market include

• NuVasive
• Life Spine
• Lanx acquired by BioMet
• X-Spine
• Pioneer Surgical
• Alphatec
• Paradigm Spine
• Spine Frontier
• Amedica Corp.
• Bioventus
• Camber Spine Technologies
• DePuy Synthes
• Implanet
• Mazor Robotics
• Meditech Spine.

The key players adopt growth strategies for product portfolio expansion by designing novel interlaminar device. The companies also have extensive distribution systems for effective sales revenue generation.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/14214

Interlaminar Device Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

According to the latest research by Future Market Insights, Bowel Stimulators market is set to witness a 6.3% growth during the year 2021-2031. The market has been developing at a gradual rate and is projected to witness lucrative growth due to increasing number of population suffering from Overactive Bladder (OAB) and rising cases of urge incontinence, like Urinary Tract Infection (UTI).  In addition, advancements in technology and development of lesser invasive procedures is likely to fuel the market demand.

What is Driving Demand for Bowel Stimulators?

A rise in disposable income, surge in incidences of Overactive Bladder, UTI and similar disorders, and development of minimally invasive procedures are primary factors boosting the market.

In addition, governments of various nations are taking initiatives to make sure that a most of the population has accessibility to inexpensive healthcare. Also, reimbursement programs of insurance companies have become promising. These factors are expected to lead to market growth.

Request a sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-14152

Also, the growing geriatric population and the associated disorders re expected to increase the demand for of bowel stimulators.

Growing incidence of urge incontinence, likely to increase the Bowel Stimulators Sales

The rising incidence of urge incontinence, like urinary tract infection (UTI) and growing occurrence of overactive bladder conditions, are the major factors responsible for the development of the market.

In addition, the increasing occurrence of fecal incontinence and the presence of medical reimbursements are certain other factors driving the market demand. According to an article published in 2019, in the Indian Journal of Community Medicine, the incidence of urinary incontinence in postmenopausal women between 45-90 years of age was about 26.47%. Besides, urinary incontinence has a considerable impact on mental and social health, which can be overcome by suitable treatment of these incontinence disorders.

US and Canada Bowel Stimulators Market Outlook

United States and Canada dominate the Bowel Stimulators market. The market is projected to witness considerable growth due to the availability of well-developed healthcare facilities, rising awareness about the prevalence and treatment of overactive bladder conditions and rapid adoption of developed medical products.

As per the CMS (Center for Medicare and Medicaid Services), urinary incontinence impacts about 13 million adults, generally women, in U.S. Bowel stimulators bring about considerable improvement in improving the quality of life for affected patients. Hence, rising incidence of fecal incontinence is likewise anticipated to boost the market in US.

Discover more about report analysis with figures and data tables, along with the table of contents. Request TOC- https://www.futuremarketinsights.com/toc/rep-gb-14152

Europe Demand Outlook for Bowel Stimulators

Europe is second dominating market and is projected to register a noteworthy growth owing to the growing geriatric population in Europe, increasing product launches, and growing healthcare expenditure in the region.

Also, the rising cases of fecal incontinence, is likely supporting the market development. As per the international neuromodulation society, in the U.K., one of the studies demonstrates that most of the elderly population are impacted by fecal incontinence.

Who are the Key Manufacturers and Suppliers of Bowel Stimulators?

Some of the leading manufacturers and suppliers of

• Bowel Stimulators include Medtronic PLC
• Axonics Inc.
• Sportaid
• Nuvectra
• Cogentix Medical
• Laborie Inc.
• B. Braun
• Cyberonics and others.

The Bowel Stimulators market is moderately competitive, with the presence of a numerous major players. New product development and launches supports organizations with increasing their market share and current product portfolio. Additionally, major players are investing greatly in the research and development to manufacture advanced products.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/14152

Bowel Stimulators Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

According to the latest research by Future Market Insights, HBsAg Testing market is set to witness a 5.9% growth during the year 2021-2031.

The market has been increasing at a gradual rate and is projected to witness lucrative growth due to increase in cirrhosis and liver cancer deaths due to prevalence of hepatitis B, technological advancements in diagnostic kits and due to increase in cirrhosis and growing awareness regarding early detection of hepatitis B.

What is Driving Demand for HBsAg Testing?

Hepatitis B is a potentially fatal infection and has turned into a vital healthcare problem across the world. Rise in prevalence of hepatitis B and need for early detection of hepatitis B are primary factors supporting the market growth.

In addition, rise in awareness among the population; and increase in initiatives by non-profit organizations and governments add to the development of the market. Increase in awareness among the patients’ leads to early detection of the disease. This is driving the demand for HBsAg testing.

Request a sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-14155

Growing research and innovation, rise in healthcare expenditure and urbanization is resulting into rapid adoption of testing procedures, which in turn leads to market growth.

Rising cases of Hepatitis B, likely to increase the HBsAg Testing Sales

Hepatitis B is an infection of worldwide importance, with a projected of 296 million people living the virus globally, according to the data provided by WHO. In the year 2019, hepatitis led to 820 000 deaths, majorly from complications such as cirrhosis and hepatocellular carcinoma.

The occurrence of hepatitis B is highest in the African and Western Pacific regions where 6.1% and 6.2% respectively of the adults are infected. Hepatitis B can lead to chronic infection and show a high risk of mortality. It is projected that 80-90% of the newborns infected with hepatitis B in first year of life suffer from chronic infections.

There is rise in prevalence of hepatitis B also because of the growing urbanization and environmental changes because of the changing lifestyle. These factors create a lucrative opportunities for hepatitis B diagnostic test manufacturers.

Discover more about report analysis with figures and data tables, along with the table of contents. Request TOC- https://www.futuremarketinsights.com/toc/rep-gb-14155

US and Canada HBsAg Testing Market Outlook

United States and Canada lead the HBsAg Testing market. The market is likely to witness significant growth owing to the high prevalence of acute cases of hepatitis B, availability of advanced diagnostic tools and rising awareness regarding hepatitis testing.

The rapid growth in the Canadian market is owing to the initiatives of the non-government and organizations. For example, the Public Health Agency of Canada conducted the World Hepatitis Day with the aim of growing awareness regarding hepatitis diagnosis. Thus, resulting into a demand surge for hepatitis diagnosis in the country.

Europe Demand Outlook for HBsAg Testing

Europe is second lucrative market and is likely to register a remarkable growth owing to the rising cases of hepatitis B infections, increasing diagnostic product launches, and growing healthcare expenditure in the region.

As per the World Health Organization, Hepatitis B is a contagious disease that affected approximately 15 million people in 2019 in the WHO European region. The growing geriatric population is also increasing the demand for hepatitis testing as complications associated with hepatitis worsen with aging.

Who are the Key Manufacturers and Suppliers of HBsAg Testing?

Some of the leading manufacturers and suppliers of HBsAg Testing include

• CTK Biotech Inc.
• Biopanda Reagents Ltd.
• Avecon Healthcare Pvt Ltd.
• Abbott
• Bio-Rad Laboratories Inc.
• Siemens Healthineers
• QIAGEN
• F. Hoffmann-La Roche AG and others.

The HBsAg Testing market is competitive, with the presence of a few major players. These global market players compete mainly on the basis of technological developments. Moreover, key players are investing greatly in the research and development to develop rapid and advanced diagnostic products.

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/14155

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

HBsAg Testing Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Sales of global manometry systems market totaled US$ 157.3 Mn in 2020. The market registered positive growth at 5.4% CAGR, reaching a valuation of US$ 279.6 Mn by the end of 2031, according to Future Market Insights’ (FMI’s) latest study.

Rising incidence of fecal incontinence and constipation, increasing elderly population, technological advancements and expansion of healthcare infrastructure are the primary factors driving the manometry system market.

Rise in number of people aged 65 years and older is expected to be the major factor boosting the growth of the manometry system market. In 2018, According to the U.S. Census Board people older than 65 years represent around 13% of the total population; this percentage is expected to reach 20% by 2031.

Request a sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-14110

Rising cases of constipation, fecal incontinence, anorectal pain, pelvic floor dyssynergia and hirschsprung’s among older population is increasing the adoption of manometry systems. Demand for these systems helps evaluate patients and provides many useful data regarding anorectal function and indicates the prognosis of treatment, particularly in the management of sphincter injuries.

Rising demand for non-invasive equipment is driving the demand for manometry system. These systems are non-invasive diagnostic procedure that can detect pressures and sensation in the anus and rectum. With this, they indicate whether the patient’s pelvic function is normal without incision into the body or removal of tissue and has low risks, and complications.

Further, rising government initiatives and funding supporting the development of product is boosting the demand for manometry system market.  Initiatives undertaken by government to enable and boost the ecosystem for the indigenous medical device industry is also stimulating market growth.

Discover more about report analysis with figures and data tables, along with the table of contents. Ask an Analyst- https://www.futuremarketinsights.com/ask-question/rep-gb-14110

Key Takeaways from Manometry System Market Study

• By product, system sheath & catheters is expected to account for the largest share of 55.0% in 2021.
• In terms of portability, stand-alone system will hold for the largest share of 55.4% in 2021 on the back of its enhanced sensitivity to provide accurate diagnosis of condition
• By end user, hospitals accounted for the largest share of 37.9% in 2021 owing to the rising demand for hospital stay that is short-term and increasing number of gastrointestinal processes.
• North America is expected to hold largest share of 38.9% in 2021 with the U.S. leading the market during the forecast period.

“As demand for manometry systems is rising due to high prevalence of gastrointestinal diseases, key players are engaging in product development that is technologically advanced for faster approvals. This is expected to give the key players a competitive edge in the industry, generating revenues,” says the FMI Analyst

Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/14110

Who is Winning?

Some of the leading manufacturers of manometry system market are focusing on product launch collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

Several joint ventures, agreements, and loan licensing procedures have influenced the market. The government of developing economies has taken several reforms to develop the market by regulating it to bring out more transparency and by allowing foreign investments in the industry.

New Product launches & approvals have emerged as key growth strategy adopted by the leading players in the manometry system market. Followed by this, acquisition was the second most key strategy adopted by the industry players. By adopting these strategies, it helped the company to expand their regional presence as well as product offerings.

For instance,

• In October 2021, “UROTECH GmbH subsidiary of Medi-Globe Group’s provided detailed information on a new clinical study for using the Magnetic Black-Star® (MBS) in paediatric urology. The MBS was an innovative product of the UROTECH GmbH, which is used in stent placement as well as stent removal of children by without performing the surgeries using the stent’ magnetic tip.”
• In May 2020, RMS Medical Devices, proudly announced it’s the acquisition of QUICKORE products for BENELUX. With this new acquisition, RMS Medical Devices adds another premium technology to its Radiology portfolio.
• In October 2020, LABORIE Medical Technologies enters into strategic partnership with Urotronic to support regulatory approval of Optilume™, a drug-coated balloon (DCB) technology for use in urethral strictures and benign prostatic hyperplasia (BPH).

• In August 2021, Medtronic Announced the FDA Approval of Next-Gen TAVR System for the treatment of symptomatic severe aortic stenosis. Next-Gen TAVR System is a self-expanding transcatheter aortic valve replacement, which is designed to enhance ease-of-use and predictable valve deployment throughout the procedure.

The key market players covered by FMI include EB Neuro S.p.A, MEDSPIRA, Medtronic, Medica S.p.A., RMS Medical Devices, MARQUAT Génie Biomédical, Diversatek Inc., Dentsleeve International Ltd., LABORIE, Prometheus Group, Smart Medical Group, Synectics Medical Limited, Medovations Inc., Sierra Scientific, and Urotech Gmbh.